secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001628280-25-041399
Event type: litigation
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Court grants preliminary approval to Ginkgo Bioworks derivative settlement; $4.125M from insurance
--------------------------------------------------------------------------------

- Company receives $4.125M from insurance; plaintiffs' counsel may request $2.75M in fees.
- Settlement requires Ginkgo to adopt corporate governance reforms.
- Derivative actions (Hu, Bowers, In re Ginkgo) will be dismissed with prejudice.
- Final hearing set for December 18, 2025; settlement entered on May 27, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828025041399/0001628280-25-041399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828025041399/dna-20250829.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-041399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer